Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases

Histopathology

Volumn 63, Issue 5, 2013, Pages 603-615

  Gao, Peng ^a   Song, Yong xi ^a   Xu, Ying ying ^a   Sun, Zhe ^a   Sun, Jing xu ^a   Xu, Hui mian ^a   Wang, Zhen ning ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Mucinous adenocarcinoma; Primary site of tumour; SEER program

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CECUM; COLON CANCER; COLORECTAL CARCINOMA; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCINOUS ADENOCARCINOMA; PRIORITY JOURNAL; RECTUM CANCER;

COLORECTAL CANCER; MUCINOUS ADENOCARCINOMA; PRIMARY SITE OF TUMOUR; SEER PROGRAM;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM;

EID: 84885424412     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12190     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012; 62; 10-29.
2. Jass JR, Sobin LH. Histologic typing of intestinal tumours, 2nd edn. Berlin: Springer-Verlag, 1989.
3. Verhulst J, Ferdinande L, Demetter P, Ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J. Clin. Pathol. 2012; 65; 381-388.
4. Song GA, Deng G, Bell I, Kakar S, Sleisenger MH, Kim YS. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. Int. J. Oncol. 2005; 26; 745-750.
5. Tanaka H, Deng G, Matsuzaki K et al. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int. J. Cancer 2006; 118; 2765-2771.
6. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000; 88; 1739-1757.
7. Kanemitsu Y, Kato T, Hirai T et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis. Colon Rectum 2003; 46; 160-167.
8. Biffi R, Botteri E, Bertani E et al. Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period. Int. J. Colorectal Dis. 2013; 28; 207-215.
9. Jivapaisarnpong P, Boonthongtho K. Clinicopathological characteristics of mucinous and non-mucinous adenocarcinoma in the colon and rectum in Rajavithi Hospital, Thailand. J. Med. Assoc. Thai. 2011; 94(Suppl 2); S41-S45.
10. Consorti F, Lorenzotti A, Midiri G, Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J. Surg. Oncol. 2000; 73; 70-74.
11. Langner C, Harbaum L, Pollheimer MJ et al. Mucinous differentiation in colorectal cancer - indicator of poor prognosis? Histopathology 2012; 60; 1060-1072.
12. Xie L, Villeneuve PJ, Shaw A. Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int. J. Oncol. 2009; 34; 1109-1115.
13. Leopoldo S, Lorena B, Cinzia A et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann. Surg. Oncol. 2008; 15; 1429-1439.
14. Yamaguchi T, Taniguchi H, Fujita S et al. Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma. Histopathology 2012; 61; 162-169.
15. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis. Colon Rectum 2005; 48; 1161-1168.
16. Du W, Mah JTL, Lee J, Sankila R, Sankaranarayanan R, Chia K-S. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis. Colon Rectum 2004; 47; 78-85.
17. Hyngstrom JR, Hu CY, Xing Y et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the national cancer data base. Ann. Surg. Oncol. 2012; 19; 2814-2821.
18. Edge SB, American Joint Committee on Cancer. AJCC cancer staging manual, 7thedn. New York, NY: Springer, 2010; xiv, 648.
19. Dunn OJ. Multiple comparisons among means. J. Am. Stat. Assoc. 1961; 56; 52-64.
20. Catalano V, Loupakis F, Graziano F et al. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann. Oncol. 2011; 23; 135-141.
21. Shin US, Yu CS, Kim JH et al. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Ann. Surg. Oncol. 2011; 18; 2232-2239.
22. Jass JR. Pathology of hereditary nonpolyposis colorectal cancer. Ann. N. Y. Acad. Sci. 2000; 910; 62-73; discussion 73-64.
23. Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur. J. Cancer 2010; 46; 2788-2798.
24. Des GuetzG, Lecaille C, Mariani P et al. Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant folfox. Anticancer Res. 2010; 30; 4297-4301.
25. Bertagnolli MM, Niedzwiecki D, Compton CC et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: cancer and leukemia group B protocol 89803. J. Clin. Oncol. 2009; 27; 1814-1821.
26. Bermejo JL, Eng C, Hemminki K. Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer. Gastroenterology 2005; 129; 1889-1899.
27. Kim ST, Lee J, Park SH et al. Clinical impact of microsatellite instability in colon cancer following adjuvant folfox therapy. Cancer Chemother. Pharmacol. 2009; 66; 659-667.
28. Millar EK, Beretov J, Sarris M, Lee CS. Mucinous differentiation in colonic adenocarcinoma is associated with a reduction in tumour-infiltrating lymphocytes. Eur. J. Surg. Oncol. 2001; 27; 273-277.
29. Shen XS, Zhao B, Wang ZJ. Clinical features and HMSH2/HMLH1 germ-line mutations in chinese patients with hereditary nonpolyposis colorectal cancer. Chin. Med. J. (Engl.) 2008; 121; 1265-1268.
30. Odone V, Chang L, Caces J, George SL, Pratt CB. The natural history of colorectal carcinoma in adolescents. Cancer 1982; 49; 1716-1720.
31. Kouraklis G, Misiakos EP. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management. Dig. Dis. Sci. 2005; 50; 336-344.